Paper7795243
Perturbation of red blood cell membrane rigidity by extracellular ligands.
Paulitschke M and 4 others. Blood, 1995. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Perturbation of red blood cell membrane rigidity by extracellular ligands. Papers, record 7795243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7795243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anion Exchange Protein 1, Erythrocyte | Major topic |
| Antibodies, Monoclonal | Major topic |
| Erythrocyte Deformability | Major topic |
| Erythrocyte Membrane | Major topic |
| Glycophorins | Major topic |
| Elasticity | |
| Erythrocytes, Abnormal | |
| Freeze Fracturing | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Ligands | |
| Membrane Fluidity |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39789834 | Dissociation of IgM antibodies from red blood cells using ethylenediamine tetraacetate/glycine acid or chloroquine diphosphate. | Transfusion | 2025 | https://conductscience.org/library/papers/39789834 | PubMed |
| 37608283 | Red blood cells: a potential delivery system. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/37608283 | PubMed |
| 36613917 | Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36613917 | PubMed |
| 36544135 | Biomimetic cell-derived nanocarriers in cancer research. | J Nanobiotechnology | 2022 | https://conductscience.org/library/papers/36544135 | PubMed |
| 35794397 | Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances. | Pharm Res | 2022 | https://conductscience.org/library/papers/35794397 | PubMed |
| 33796822 | Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy. | Cancer Drug Resist | 2020 | https://conductscience.org/library/papers/33796822 | PubMed |
| 33052588 | Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/33052588 | PubMed |
| 31834794 | Rational Design of a Bifunctional AND-Gate Ligand To Modulate Cell-Cell Interactions. | ACS Synth Biol | 2020 | https://conductscience.org/library/papers/31834794 | PubMed |
| 29365311 | Biocompatible coupling of therapeutic fusion proteins to human erythrocytes. | Blood Adv | 2018 | https://conductscience.org/library/papers/29365311 | PubMed |
| 27856317 | Drug delivery by erythrocytes: "Primum non nocere". | Transfus Apher Sci | 2016 | https://conductscience.org/library/papers/27856317 | PubMed |
| 27836986 | Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury. | FASEB J | 2017 | https://conductscience.org/library/papers/27836986 | PubMed |
| 27707522 | Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond. | Transfus Med Rev | 2017 | https://conductscience.org/library/papers/27707522 | PubMed |
| 27580023 | Diffusion of glycophorin A in human erythrocytes. | Biochim Biophys Acta | 2016 | https://conductscience.org/library/papers/27580023 | PubMed |
| 27488382 | Anti-erythrocyte antibodies may contribute to anaemia in Plasmodium vivax malaria by decreasing red blood cell deformability and increasing erythrophagocytosis. | Malar J | 2016 | https://conductscience.org/library/papers/27488382 | PubMed |
| 26941164 | Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems. | Adv Drug Deliv Rev | 2016 | https://conductscience.org/library/papers/26941164 | PubMed |
| 26228773 | Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier. | Ther Deliv | 2015 | https://conductscience.org/library/papers/26228773 | PubMed |
| 23944874 | Identification of binding domains on red blood cell glycophorins for Babesia divergens. | Transfusion | 2014 | https://conductscience.org/library/papers/23944874 | PubMed |
| 21283643 | A rigidity-enhanced antimicrobial activity: a case for linear cationic α-helical peptide HP(2-20) and its four analogues. | PLoS One | 2011 | https://conductscience.org/library/papers/21283643 | PubMed |
| 20192900 | Drug delivery by red blood cells: vascular carriers designed by mother nature. | Expert Opin Drug Deliv | 2010 | https://conductscience.org/library/papers/20192900 | PubMed |
| 19343220 | The homeostasis of Plasmodium falciparum-infected red blood cells. | PLoS Comput Biol | 2009 | https://conductscience.org/library/papers/19343220 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GYPA | 2993 | PubTator's text mining | https://conductscience.org/library/genes/2993 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7795243
GET https://conductscience.org/api/papers/v1/7795243/cited_by?page=2